We improve the Quality of Life for People with Diabetes.

Investor Relations

Sensile Medical is a privately owned company. Its investor relations activities are primarily directed towards its current shareholders. A regular and ongoing information policy for its shareholders has been established.

Sensile Medical has a solid financing coming primarily from private sources – individuals or organisations who believe in the promise and potential of the people and technologies of Sensile Medical. Several public fundings such as CTI fundings are also included which validates the excellence of the technology innovations of Sensile Medical.

With a lean management structure and overhead, the funds raised to date can be used mainly to move Sensile Medical’s technology and product development forward and to establish mutually beneficial collaborations.